- Recent Articles
- Most Citedi
- Most Visitedi
- Future Articles
-
Original Article04-11-1998
Prenatal diagnosis of fetal lung maturity in high-risk pregnancies
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):315-321
Views80PlumX Metrics- Citations
- Citation Indexes: 2
- Usage
- Full Text Views: 41034
- Abstract Views: 1176
- Captures
- Readers: 9
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticlePrenatal diagnosis of fetal lung maturity in high-risk pregnancies
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):315-321
DOI 10.1590/S0100-72031998000600004
Views80See moreThe objective was to evaluate the accuracy of the foam stability test, lecithin/sphingomyelin (LS) ratio, presence of phosphatidylglycerol (PG) and lung profile (L/S ratio > 1.7 and PG present simultaneously) in 121 consecutive high-risk gestations at the São Paulo Hospital from January 1990 to January 1995. Delivery occurred within 3 days of fetal lung maturation testing. This is a prospective study in which the sensitivity, specificity, positive (PPV) and negative predictive value (NPV) of all the tests were determined. Neonatal respiratory outcome and amniocentesis results were stratified by gestational age for comparison. The distribution of the studied population according to maternal pathology was diabetes mellitus (48), hypertensive disorders (41), Rh isoimmunization (14) and miscellaneous (18). Respiratory distress (RD) was present in 33 infants (27.2%), mainly in the diabetic group. There was no false negative using lung profile (all patients) and foam stability tests among hypertensive pregnancies (specificity 100%), but there were about 20% to 50% false positives in the other tests. Overall, all four tests had a low PPV: 23% for foam test, 51% for L/S ratio, 63% for PG, 61% for lung profile, and high NPV: 92% for foam test, 88% for L/S ratio, 89% for PG and 100% for lung profile. All tests had less accuracy in the diabetic pregnant women. This study shows that the presence of PG and L/S ratio > 1.7 in the amniotic fluid of high-risk pregnancies confirms maturity with a very low risk to develop RD and that the foam stability test was useful as a first-line test to predict the absence of surfactant-deficient respiratory distress syndrome, particularly in hypertensive pregnant women.
PlumX Metrics- Citations
- Citation Indexes: 2
- Usage
- Full Text Views: 41034
- Abstract Views: 1176
- Captures
- Readers: 9
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article04-11-1998
The effects of nomegestrol acetate subdermal implant on carbohydrate metabolism, serum lipoproteins and on hepatic function
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):309-313
Views108PlumX Metrics- Usage
- Full Text Views: 12497
- Abstract Views: 1415
- Captures
- Readers: 7
- Social Media
- Shares, Likes & Comments: 6
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleThe effects of nomegestrol acetate subdermal implant on carbohydrate metabolism, serum lipoproteins and on hepatic function
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):309-313
DOI 10.1590/S0100-72031998000600003
Views108Objective: to evaluate variations in body weight, arterial blood pressure, fasting glucose, HbA1C, insulin, total cholesterol, HDL-C, LDL-C, triglycerides, Sgot, SGPT, GGT and bilirubin in women bearing a single subdermal Silastic implant containing 55 mg (+ 10%) of nomegestrol acetate during two years. Methods: eighteen healthy volunteers of reproductive age who desired to use anticonceptive drugs and who did not present contraindications to hormonal contraception participated in the study. All women were investigated before starting treatment and were followed-up for two years. At the end of the first year the capsules were inserted. Results: body weight increased from 54.9 + 1.5 kg at admission to 55.3 + 2.0 kg at 12 months of use (p<0.05) and from 56.0 + 2.7 kg at 24 months of use. There was a slight increase in arterial blood pressure, both systolic and diastolic, at month 12 (p<0.01). At month 24, the arterial blood pressure was not significantly different from the values at admission. All values were within the normal range. Insulin, HbA1C, LDL-C and GGT remained unchanged during the use of the implant. A significant decrease in total cholesterol (p<0.05) was observed in the third month and of HDL-C (p<0.01) in the sixth month. All lipoprotein alterations were inconsistent and values were within the normal range. Significant increases in fast glucose (p<0.05 and p<0.01) were observed in the third and sixth months, respectively. Significant SGOT decreases (p<0.05, p<0.01 and p<0.05) were observed in months 6, 18 and 24, respectively, and of SGPT (p<0.05) in month 18. Significant bilirubin increase (p<0.05) was observed only in the third month of implant use. All these variations remained within the normal range. Conclusions: these results show that, within the normal range, fasting glucose variations do not correlate with alterations in insulin levels. The slight serum lipoprotein, SGTO, SGPT and insulin alterations were transient. No clinical effects could be observed regarding lipoproteins, carbohydrate metabolism, insulin levels and liver function among the users during the two years.
Key-words ContraceptionCorbohydrate metabolismInjectable contraceptive drugsLiver functionProgesteroneSee morePlumX Metrics- Usage
- Full Text Views: 12497
- Abstract Views: 1415
- Captures
- Readers: 7
- Social Media
- Shares, Likes & Comments: 6
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article04-11-1998
Mammographic density variation in users and nonusers of hormonal replacement therapy
- Cesar Cabello dos Santos,
- Aarão Mendes Pinto-Neto,
- Lúcia Helena Simões Costa-Paiva,
- Henrique Benedito Brenelli
Views87This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleMammographic density variation in users and nonusers of hormonal replacement therapy
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):303-308
DOI 10.1590/S0100-72031998000600002
- Cesar Cabello dos Santos,
- Aarão Mendes Pinto-Neto,
- Lúcia Helena Simões Costa-Paiva,
- Henrique Benedito Brenelli
Views87See moreObjective: to compare mammographic density changes, case by case, according to image digitization in three consecutive evaluations of users or nonusers of hormonal replacement therapy (HRT). Methods: 59 postmenopausal women were evaluated, 43 being users of cyclic or continuous estro-progestin hormonal replacement therapy, and 16 nonusers. The criteria of inclusion were: amenorrhea for at least 12 months, a normal mammographic examination at the beginning of the HRT (users) or the clinical follow-up without HRT (nonusers), at two incidences (mediolateral and craniocaudal). The following variables were used for the evaluation of mammary density: initial change – the difference between the first mammography after HRT performed in 12 ± 3 months and the mammography performed before HRT-and final change – the difference between the second mammography after HRT performed in 24 ± 3 months and the mammography performed before HRT. Wilcoxon and c² tests were used in order to evaluate the differences in mammographic density changes. Results: more than half (56.3%) of the women, HRT users with initial increase in mammographic density remained with the increase after the final evaluation. This finding was not significant (p=0.617). In the same group, the initial nonincrease was significantly associated with the final nonincrease (p=0.017). Among the nonusers, all breasts that were not totally fat at the initial evaluation presented a mammographic density decrease at the final evaluation. Conclusions: the majority of HRT users presenting mammographic density increase at the first evaluation, after approximately one year of use, remained with the increase at a second evaluation. After some time, the nonusers tended to present a significant mammographic density decrease (p=0.003).
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
04-11-1998
A FEBRASGO e as ações voltadas para a promoção da saúde
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):301-301
Views55This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
A FEBRASGO e as ações voltadas para a promoção da saúde
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(6):301-301
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
04-10-1998
Avaliação longitudinal de aspectos imunológicos e virológicos durante a gravidez e puerpério em mulheres portadoras do vírus da imunodeficiência humana tipo 1 (HIV-1)
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):170-170
Views90This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Avaliação longitudinal de aspectos imunológicos e virológicos durante a gravidez e puerpério em mulheres portadoras do vírus da imunodeficiência humana tipo 1 (HIV-1)
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):170-170
DOI 10.1590/S0100-72031998000300011
Views90Avaliação Longitudinal de Aspectos Imunológicos e Virológicos Durante a Gravidez e Puerpério em Mulheres Portadoras do Vírus da Imunodeficiência Humana Tipo 1 (HIV-1)[…]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
04-10-1998
A dopplervelocimetria com mapeamento em cores dos ramos intramiometriais da artéria uterina de mulheres na pós-menopausa, com e sem carcinoma de endométrio
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):169-170
Views72This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
A dopplervelocimetria com mapeamento em cores dos ramos intramiometriais da artéria uterina de mulheres na pós-menopausa, com e sem carcinoma de endométrio
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):169-170
DOI 10.1590/S0100-72031998000300010
Views72A Dopplervelocimetria com Mapeamento em Cores dos Ramos Intramiometriais da Artéria Uterina de Mulheres na Pós-Menopausa, com e sem Carcinoma de Endométrio[…]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
04-10-1998
Avaliação da esteroidogênese das supra-renais em mulheres normais por meio dos testes de ACTH simples de depósito
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):169-169
Views71This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Avaliação da esteroidogênese das supra-renais em mulheres normais por meio dos testes de ACTH simples de depósito
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):169-169
DOI 10.1590/S0100-72031998000300009
Views71Avaliação da Esteroidogênese das Supra-Renais em Mulheres Normais por Meio dos Testes de ACTH Simples de Depósito[…]See moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Case Report04-10-1998
Recurrent HELLP syndrome: report on two cases
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):165-167
Views73PlumX Metrics- Usage
- Full Text Views: 187810
- Abstract Views: 1941
- Captures
- Readers: 10
- Social Media
- Shares, Likes & Comments: 4
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Case ReportRecurrent HELLP syndrome: report on two cases
Revista Brasileira de Ginecologia e Obstetrícia. 1998;20(3):165-167
DOI 10.1590/S0100-72031998000300008
Views73See moreHELLP syndrome is a severe complication of preeclampsia that increases maternal and perinatal morbidity and mortality. Two cases of recurrent HELLP syndrome are described, maternal death occurring in one of the cases. This study is a warning about the increased risk of HELLP syndrome in the next pregnancy.
PlumX Metrics- Usage
- Full Text Views: 187810
- Abstract Views: 1941
- Captures
- Readers: 10
- Social Media
- Shares, Likes & Comments: 4
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
-
Original Article07-20-2004
Search for human papillomavirus in samples of normal endometrial tissue and tissue with carcinoma by the PCR technique
- Edison Natal Fedrizzi,
- Newton Sérgio de Carvalho,
- Luisa Lina Villa,
- Irene Vieira de Souza,
- Ana Paula Martins Sebastião
Views125912This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleSearch for human papillomavirus in samples of normal endometrial tissue and tissue with carcinoma by the PCR technique
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(4):277-287
DOI 10.1590/S0100-72032004000400003
- Edison Natal Fedrizzi,
- Newton Sérgio de Carvalho,
- Luisa Lina Villa,
- Irene Vieira de Souza,
- Ana Paula Martins Sebastião
Views125912See moreOBJECTIVE: to compare the prevalence of DNA of human papillomavirus (HPV), in samples of normal endometrial tissue, and tissue with endometrial carcinoma of women submitted to surgical treatment (hysterectomy), or between endometrial carcinoma and benign disease, through the PCR technique. METHODS: this is an observational control-case study where 100 women (50 with endometrial carcinoma and 50 with normal endometrial tissue) were analyzed for the detection of HPV DNA in samples of endometrial tissue kept in paraffin blocks by the PCR technique. The cases of endometrial carcinoma with uncertain primary site of the lesion as well as the cases with previous or current history of pre-neoplasic lesions or carcinoma of the lower genital tract were excluded. Variables as age, smoking habit, endometrial trophism, squamous differentiation and degree of tumor differentiation were also evaluated. RESULTS: the estimated relative risk of the presence of HPV in the endometrial carcinoma and in the normal endometrial tissue was the same. HPV was detected in 8% of the cases of carcinoma and 10% in the normal endometrial tissue. In spite of HPV having been 3.5 times more detected in women with smoking habit in the group without carcinoma, there was no statistical difference. The presence of HPV was also not correlated with the women’s age, endometrial trophism, squamous differentiation and degree of tumor differentiation. The HPV types 16 (5 cases) and 18 (4 cases) were the viruses most frequently found both in the normal endometrial tissue or in the tissue with carcinoma. No oncogenic low risk virus was detected in the samples. CONCLUSION: The same proportion of HPV is present in the endometrial tissue of women with endometrial cancer and with normal endometrium. It could not be demonstrated a possible correlation of DNA of HPV with the development of endometrial carcinoma.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
FEBRASGO POSITION STATEMENT04-25-2024
Hyperprolactinemia in women: diagnostic approach
- Andrea Glezer
,
- Heraldo Mendes Garmes
,
- Leandro Kasuki
,
- Manoel Martins
,
- Paula Condé Lamparelli Elias
,
[ … ], - Andrea Prestes Nácul
Views1202This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTHyperprolactinemia in women: diagnostic approach
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS04
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Andrea Glezer
-
FEBRASGO POSITION STATEMENT04-25-2024
Hyperprolactinemia in women: treatment
- Cristina Laguna Benetti-Pinto
,
- Andrea Prestes Nácul
,
- Ana Carolina Japur Rosa e Silva
,
- Gustavo Arantes Rosa Maciel
,
- Vania dos Santos Nunes Nogueira
,
[ … ], - Andrea Glezer
Views1200This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTHyperprolactinemia in women: treatment
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS05
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Cristina Laguna Benetti-Pinto
-
FEBRASGO POSITION STATEMENT00-00-2024
Breech birth care: Number 1 – 2024
- Álvaro Luiz Lage Alves
,
- Alexandre Massao Nozaki
,
- Carla Betina Andreucci Polido
,
- Lucas Barbosa da Silva
,
- Roxana Knobel
Views1004This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTBreech birth care: Number 1 – 2024
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgofps1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Álvaro Luiz Lage Alves
-
Letter to the Editor04-09-2024
Letter to Editor: In response to existence of SARS-CoV-2 in the peritoneal fluid
- Gustavo Romero-Velez
,
- Guillermo Ponce de Leon-Ballesteros
,
- Juan Barajas-Gamboa
,
- Jerry Dang
,
- Andrew Strong
,
[ … ], - Mathew Kroh
Abstract
Letter to the EditorLetter to Editor: In response to existence of SARS-CoV-2 in the peritoneal fluid
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo24
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Gustavo Romero-Velez
-
FEBRASGO POSITION STATEMENT04-02-2024
Use of hormones and risk of venous thromboembolism
- Venina Isabel Poço Viana Leme de Barros
,
- André Luiz Malavasi Longo de Oliveira
,
- Denis Jose do Nascimento
,
- Eduardo Zlotnik
,
- Marcelo Melzer Teruchkin
,
[ … ], - Paulo Francisco Ramos Margarido
Views832This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTUse of hormones and risk of venous thromboembolism
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS02
- Venina Isabel Poço Viana Leme de Barros
,
- André Luiz Malavasi Longo de Oliveira
,
- Denis Jose do Nascimento
,
- Eduardo Zlotnik
,
- Marcelo Melzer Teruchkin
,
- Marcos Arêas Marques
,
- Paulo Francisco Ramos Margarido
Views832See moreKey points
•The risk of venous thromboembolism (VTE) is not increased in women using long-acting reversible contraceptive methods (LARCs) with progestogens.
•Oral contraceptives with levonorgestrel or norgestimate confer half the risk of VTE compared to oral contraceptives containing desogestrel, gestodene or drospirenone.
•Progestogen-only pills do not confer an increased risk of VTE.
•Women using transdermal contraceptive patches and combined oral contraceptives (COCs) are at an approximately eight times greater risk of VTE than non-users of hormonal contraceptives (HCs), corresponding to 9.7 events per 10,000 women/years.
•Vaginal rings increase the risk of VTE by 6.5 times compared to not using HC, corresponding to 7.8 events per 10,000 women/years.
•Several studies have demonstrated an increased risk of VTE in transgender individuals receiving hormone therapy (HT).
•Hormone therapy during menopause increases the risk of VTE by approximately two times, and this risk is increased by obesity, thrombophilia, age over 60 years, surgery and immobilization.
•The route of estrogen administration, the dosage and type of progestogen associated with estrogen may affect the risk of VTE in the climacteric.
•Combined estrogen-progesterone therapy increases the risk of VTE compared to estrogen monotherapy.
•Postmenopausal HT increases the risk of thrombosis at atypical sites.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Venina Isabel Poço Viana Leme de Barros
-
Editorial00-00-2024
The path to elimination: FEBRASGO 2023’s targeted strategies against cervical cancer in Brazil
- Agnaldo Lopes da Silva Filho
,
- Cecilia Maria Roteli-Martins
,
- Neila Maria de Góis Speck
,
- Newton Sérgio de Carvalho
,
- Eduardo Batista Cândido
,
[ … ], - Júlio César Teixeira
Views820This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
EditorialThe path to elimination: FEBRASGO 2023’s targeted strategies against cervical cancer in Brazil
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgoedt2
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Agnaldo Lopes da Silva Filho
-
FEBRASGO POSITION STATEMENT04-02-2024
Vulvovaginitis in pregnant women
- Geraldo Duarte
,
- Iara Moreno Linhares
,
- Regis Kreitchmann
,
- Andréa da Rocha Tristão
,
- Evelyn Traina
,
[ … ], - Joelma Queiroz Andrade
Views786This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTVulvovaginitis in pregnant women
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS03
- Geraldo Duarte
,
- Iara Moreno Linhares
,
- Regis Kreitchmann
,
- Andréa da Rocha Tristão
,
- Evelyn Traina
,
- Ivete Canti
,
- Marcos Takimura
,
- Joelma Queiroz Andrade
Views786See moreKey points
• The balanced vaginal microbiome is the main factor defending the vaginal environment against infections. Lactobacilli play a key role in this regard, maintaining the vaginal pH within the normal range (3.8 to 4.5).
•Hormonal and immune adaptations resulting from pregnancy influence changes in the vaginal microbiome during pregnancy.
•An altered vaginal microbiome predisposes to human immunodeficiency virus (HIV) infection.
•Bacterial vaginosis is the main clinical expression of an imbalanced vaginal microbiome.
•Vulvovaginal candidiasis depends more on the host’s conditions than on the etiological agent.
•Trichomonas vaginalis is a protozoan transmitted during sexual intercourse.
•The use of probiotics is not approved for use in pregnant women.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Geraldo Duarte
-
FEBRASGO POSITION STATEMENT06-27-2019
Pre-eclampsia/Eclampsia
- José Carlos Peraçoli
,
- Vera Therezinha Medeiros Borges,
- José Geraldo Lopes Ramos,
- Ricardo de Carvalho Cavalli,
- Sérgio Hofmeister de Almeida Martins Costa, [ … ],
- Edson Viera da Cunha Filho
Views98This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
FEBRASGO POSITION STATEMENTPre-eclampsia/Eclampsia
Revista Brasileira de Ginecologia e Obstetrícia. 2019;41(5):318-332
- José Carlos Peraçoli
,
- Vera Therezinha Medeiros Borges,
- José Geraldo Lopes Ramos,
- Ricardo de Carvalho Cavalli,
- Sérgio Hofmeister de Almeida Martins Costa,
- Leandro Gustavo de Oliveira,
- Francisco Lazaro Pereira de Souza,
- Henri Augusto Korkes,
- Ione Rodrigues Brum,
- Maria Laura Costa,
- Mário Dias Corrêa Junior,
- Nelson Sass,
- Angélica Lemos Debs Diniz,
- Caio Antonio de Campos Prado,
- Edson Viera da Cunha Filho
Views98See moreAbstract
Pre-eclampsia is a multifactorial and multisystemic disease specific to gestation. It is classically diagnosed by the presence of hypertension associated with proteinuria manifested in a previously normotensive pregnant woman after the 20th week of gestation. Pre-eclampsia is also considered in the absence of proteinuria if there is target organ damage. The present review takes a general approach focused on aspects of practical interest in the clinical and obstetric care of these women. Thus, it explores the still unknown etiology, current aspects of pathophysiology and of the diagnosis, the approach to disease prediction, its adverse outcomes and prevention. Management is based on general principles, on nonpharmacological and on pharmacological clinical treatment of severe or nonsevere situations with emphasis on the hypertensive crisis and eclampsia. Obstetric management is based on preeclampsia without or with signs of clinical and/or laboratory deterioration, stratification of gestational age
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - José Carlos Peraçoli
-
Original Article02-01-2019
Syphilis in Pregnancy: The Reality in a Public Hospital
- Rafael Garcia Torres,
- Ana Laura Neves Mendonça,
- Grazielle Cezarine Montes,
- Jacqueline Jácome Manzan,
- João Ulisses Ribeiro, [ … ],
- Marina Carvalho Paschoini
Views281PlumX Metrics- Citations
- Citation Indexes: 19
- Policy Citations: 1
- Usage
- Full Text Views: 2342
- Abstract Views: 376
- Captures
- Readers: 212
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleSyphilis in Pregnancy: The Reality in a Public Hospital
Revista Brasileira de Ginecologia e Obstetrícia. 2019;41(2):90-96
- Rafael Garcia Torres,
- Ana Laura Neves Mendonça,
- Grazielle Cezarine Montes,
- Jacqueline Jácome Manzan,
- João Ulisses Ribeiro,
- Marina Carvalho Paschoini
Views281See moreAbstract
Objective:
The present study assessed epidemiological and obstetrical data from pregnant women with syphilis at the Hospital de Clínicas of the Universidade Federal do Triângulo Mineiro (UFTM, in the Portuguese acronym), describing this disease during pregnancy and its vertical transmission for future healthcare actions.
Methods:
Records from pregnant women who had been admitted to the Obstetrics Department of the Hospital de Clínicas of the UFTM and were diagnosed with syphilis between 2007 and 2016 were reviewed. A standardized form was used to collect epidemiological, obstetric data and outcomes of congenital infection. The present research has been authorized by the Ethics Committee of the institution.
Results:
There were 268 women diagnosed with syphilis, with an average age of 23.6 years old. The majority of the patients were from Uberaba. Inadequate prenatal care was observed in 37.9% of the pregnant women. Only 34.2% of the patients completed the treatment according to the guidelines issued by the Ministry of Health of Brazil, and 19.8% of the partners of the patients underwent adequate syphilis treatment; 37 (13.8%) couples (patients and partners) underwent correct treatment. Regarding the obstetric outcomes, 4 (1.5%) patients had a miscarriage and 8 (3.4%) had fetal losses (from the fetal loss group, 7 had no adequate treatment); 61 (25.9%) patients had premature births – this prematurity has been significantly correlated to inadequate or incomplete treatment in 49 (27.9%) patients, compared with 12 (13.0%) patients with premature births and adequate treatment (p = 0.006). The average live newborn weight was 2,840 g; 25.3% had a birth weight < 2,500 g; 74.2% had congenital syphilis, a data with heavy correlation to inadequate or incomplete prenatal care, prematurity, and low birth weight.
Conclusion:
Public awareness policies on adequate prenatal care, intensification of serological screening, and early treatment of syphilis are needed, considering the rise of cases diagnosed during gestation and its potentially preventable deleterious consequences related to congenital transmission.
PlumX Metrics- Citations
- Citation Indexes: 19
- Policy Citations: 1
- Usage
- Full Text Views: 2342
- Abstract Views: 376
- Captures
- Readers: 212
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Systematic Review05-01-2017
Zika Virus Infection in Pregnant Women and Microcephaly
- Geraldo Duarte,
- Antonio Fernandes Moron,
- Artur Timerman,
- César Eduardo Fernandes,
- Corintio Mariani Neto, [ … ],
- Rossana Pulcineli Vieira Francisco
Views372This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Systematic ReviewZika Virus Infection in Pregnant Women and Microcephaly
Revista Brasileira de Ginecologia e Obstetrícia. 2017;39(5):235-248
- Geraldo Duarte,
- Antonio Fernandes Moron,
- Artur Timerman,
- César Eduardo Fernandes,
- Corintio Mariani Neto,
- Gutemberg Leão de Almeida Filho,
- Heron Werner Junior,
- Hilka Flavia Barra do Espírito Santo,
- João Alfredo Piffero Steibel,
- João Bortoletti Filho,
- Juvenal Barreto Borriello de Andrade,
- Marcelo Burlá,
- Marcos Felipe Silva de Sá,
- Newton Eduardo Busso,
- Paulo César Giraldo,
- Renato Augusto Moreira de Sá,
- Renato Passini Junior,
- Rosiane Mattar,
- Rossana Pulcineli Vieira Francisco
Views372Abstract
From the discovery of the Zika virus (ZIKV) in 1947 in Uganda (Africa), until its arrival in South America, it was not known that it would affect human reproductive life so severely. Today, damagetothe central nervous system is known to be multiple, and microcephaly is considered the tip of the iceberg. Microcephaly actually represents the epilogue of this infection’s devastating process on the central nervous system of embryos and fetuses. As a result of central nervous system aggression by the ZIKV, this infection brings the possibility of arthrogryposis, dysphagia, deafness and visual impairment. All of these changes of varying severity directly or indirectly compromise the future life of these children, and are already considered a congenital syndrome linked to the ZIKV. Diagnosis is one of the main difficulties in the approach of this infection. Considering the clinical part, it has manifestations common to infections by the dengue virus and the chikungunya fever, varying only in subjective intensities. The most frequent clinical variables are rash, febrile state, non-purulent conjunctivitis and arthralgia, among others. In terms of laboratory resources, there are also limitations to the subsidiary diagnosis. Molecular biology tests are based on polymerase chain reaction (PCR)with reverse transcriptase (RT) action, since the ZIKV is a ribonucleic acid (RNA) virus. The RT-PCR shows serum or plasma positivity for a short period of time, no more than five days after the onset of the signs and symptoms. The ZIKVurine test is positive for a longer period, up to 14 days. There are still no reliable techniques for the serological diagnosis of this infection. If there are no complications (meningoencephalitis or Guillain-Barré syndrome), further examination is unnecessary to assess systemic impairment. However, evidence is needed to rule out other infections that also cause rashes, such as dengue, chikungunya, syphilis, toxoplasmosis, cytomegalovirus, rubella, and herpes. There is no specific antiviral therapy against ZIKV, and the therapeutic approach to infected pregnant women is limited to the use of antipyretics and analgesics. Anti-inflammatory drugs should be avoided until the diagnosis of dengue is discarded. There is no need to modify the schedule of prenatal visits for pregnant women infected by ZIKV, but it is necessary to guarantee three ultrasound examinations during pregnancy for low-risk pregnancies, and monthly for pregnant women with confirmed ZIKV infection. Vaginal delivery and natural breastfeeding are advised.
Key-words arbovirus infectionsblindness/ etiologydeafness/ etiologymicrocephaly/ ultrasonographyPregnancy complicationsReal-time polymerase chain reactionZika virusSee moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Editorial09-25-2020
COVID-19 and Maternal Death in Brazil: An Invisible Tragedy
- Marcos Nakamura-Pereira
,
- Melania Maria Ramos Amorim
,
- Rodolfo de Carvalho Pacagnella
,
- Maira Libertad Soligo Takemoto
,
- Fatima Cristina Cunha Penso
,
[ … ], - Maria do Carmo Leal
Views183PlumX Metrics- Citations
- Citation Indexes: 31
- Policy Citations: 2
- Usage
- Full Text Views: 1855
- Captures
- Readers: 138
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
EditorialCOVID-19 and Maternal Death in Brazil: An Invisible Tragedy
Revista Brasileira de Ginecologia e Obstetrícia. 2020;42(8):445-447
- Marcos Nakamura-Pereira
,
- Melania Maria Ramos Amorim
,
- Rodolfo de Carvalho Pacagnella
,
- Maira Libertad Soligo Takemoto
,
- Fatima Cristina Cunha Penso
,
- Jorge de Rezende-Filho
,
- Maria do Carmo Leal
Views183The infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for causing the coronavirus disease 2019 (COVID-19), became a devastating threat to the health of the world population and was declared a global pandemic by the World Health Organization (WHO) on March 11, 2020. Beginning in China at the end […]See morePlumX Metrics- Citations
- Citation Indexes: 31
- Policy Citations: 2
- Usage
- Full Text Views: 1855
- Captures
- Readers: 138
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Marcos Nakamura-Pereira
-
Original Article04-01-2017
Influence of Body Image in Women Undergoing Treatment for Breast Cancer
- Ana Carolina Lagos Prates,
- Ruffo Freitas-Junior,
- Mariana Ferreira Oliveira Prates,
- Márcia de Faria Veloso,
- Norami de Moura Barros
Views263This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleInfluence of Body Image in Women Undergoing Treatment for Breast Cancer
Revista Brasileira de Ginecologia e Obstetrícia. 2017;39(4):175-183
- Ana Carolina Lagos Prates,
- Ruffo Freitas-Junior,
- Mariana Ferreira Oliveira Prates,
- Márcia de Faria Veloso,
- Norami de Moura Barros
Views263See moreAbstract
Objective
The objective of this study was to investigate the self-esteem of women with and without breast cancer regarding their body image.
Methods
A quantitative, case-control study in which 90 women with breast cancer were evaluated in the case group, and 77 women without breast cancer in the control group. For data collection, the body satisfaction scale (BSS), a scale adapted and validated in Brazil, and the Rosenberg self-esteem questionnaire were used. For the statistical analysis of the data, the Statistical Package for the Social Sciences software (IBM-SPSS, Chicago, Il, US), version 16.0 was used.
Results
Compared with the women without breast cancer, those with breast cancer were more dissatisfied with body image related to appearance. Women undergoing neoadjuvant chemotherapy were more dissatisfied with their appearance compared with those with cancer who were not undergoing this treatment. Mastectomy also accounted for more dissatisfaction concerning appearance among women who underwent the procedure compared with the women who were submitted to breast-conserving therapy.
Conclusion
Women with breast cancer were more dissatisfied with their body image compared with those without breast cancer, particularly following mastectomy or during chemotherapy. The self-esteem was found to be negatively affected in patients who were dissatisfied with their body image.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article01-01-2018
Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST)
- Aline Henz,
- Charles Francisco Ferreira,
- Carolina Leão Oderich,
- Carin Weirich Gallon,
- Juliana Rintondale Sodré de Castro, [ … ],
- Maria Celeste Osório Wender
Views445PlumX Metrics- Citations
- Citation Indexes: 43
- Usage
- Full Text Views: 3592
- Abstract Views: 929
- Captures
- Readers: 153
- Mentions
- News Mentions: 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticlePremenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST)
Revista Brasileira de Ginecologia e Obstetrícia. 2018;40(1):20-25
- Aline Henz,
- Charles Francisco Ferreira,
- Carolina Leão Oderich,
- Carin Weirich Gallon,
- Juliana Rintondale Sodré de Castro,
- Maiara Conzatti,
- Marcelo Pio de Almeida Fleck,
- Maria Celeste Osório Wender
Views445Abstract
Objective
To validate the premenstrual symptoms screening tool (PSST) in relation to the daily record of severity of problems (DRSP) for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) diagnoses.
Methods
A cross-sectional study with 127 women (20 45 years) with PMS complaints. The women were evaluated in terms of weight, height and body mass index (BMI). After using the primary care evaluation of mental disorders (PRIME-MD) questionnaire to exclude the diagnosis of depression, the PSST was completed and the women were instructed to fill out the DRSP for two consecutive menstrual cycles. The agreement between the two questionnaires was assessed by the Kappa (k) and the prevalence-adjusted, bias-adjusted kappa (PABAK) values.
Results
Two-hundred and eighty-two women met the eligibility criteria and answered the PSST. The DRSP was completed for two cycles by 127 women. The percentages of women with PMS and PMDD diagnoses by the DRSP were 74.8% and 3.9% respectively; by PSST, the percentages were41.7% and 34.6% respectively. The number of patients considered “normal” (with symptoms below the threshold for the diagnosis of PMS) was similar in both questionnaires. There was no agreement (Kappa = 0.12) in the results of PMS/ PMDD diagnosis (the PABAK coefficient confirmed this result = 0.39). The PSST had a high sensitivity (79%) and a low specificity (33.3%) for PMS/PMDD diagnosis.
Conclusion
The PSST should be considered a diagnostic screening tool. Positive PMS/PMDD cases by PSST should be further evaluated by DRSP to confirm the diagnosis.
Key-words Diagnosispremenstrual dysphoric disorderPremenstrual syndromeQuestionnaireSigns and symptomsSee morePlumX Metrics- Citations
- Citation Indexes: 43
- Usage
- Full Text Views: 3592
- Abstract Views: 929
- Captures
- Readers: 153
- Mentions
- News Mentions: 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Review Article07-01-2017
Abnormal Uterine Bleeding
- Cristina Laguna Benetti-Pinto,
- Ana Carolina Japur de Sá Rosa-e-Silva,
- Daniela Angerame Yela,
- José Maria Soares Júnior
Views293This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Review ArticleAbnormal Uterine Bleeding
Revista Brasileira de Ginecologia e Obstetrícia. 2017;39(7):358-368
- Cristina Laguna Benetti-Pinto,
- Ana Carolina Japur de Sá Rosa-e-Silva,
- Daniela Angerame Yela,
- José Maria Soares Júnior
Views293Abstract
Abnormal uterine bleeding is a frequent condition in Gynecology. It may impact physical, emotional sexual and professional aspects of the lives of women, impairing their quality of life. In cases of acute and severe bleeding, women may need urgent treatment with volumetric replacement and prescription of hemostatic substances. In some specific cases with more intense and prolonged bleeding, surgical treatment may be necessary. The objective of this chapter is to describe the main evidence on the treatment of women with abnormaluterinebleeding, both acuteand chronic.Didactically,thetreatmentoptions were based on the current International Federation of Gynecology and Obstetrics (FIGO) classification system (PALM-COEIN). The etiologies of PALM-COEIN are: uterine Polyp (P), Adenomyosis (A), Leiomyoma (L), precursor and Malignant lesions of the uterine body (M), Coagulopathies (C), Ovulatory dysfunction (O), Endometrial dysfunction (E), Iatrogenic (I), and Not yet classified (N). The articles were selected according to the recommendation grades of the PubMed, Cochrane and Embase databases, and those in which the main objective was the reduction of uterine menstrual bleeding were included. Only studies written in English were included. All editorial or complete papers that were not consistent with abnormal uterine bleeding, or studies in animal models, were excluded. The main objective of the treatment is the reduction of menstrual flow and morbidity and the improvement of quality of life. It is important to emphasize that the treatment in the acute phase aims to hemodynamically stabilize the patient and stop excessive bleeding, while the treatment in the chronic phase is based on correcting menstrual dysfunction according to its etiology and clinical manifestations. The treatment may be surgical or pharmacological, and thelatterisbasedmainlyonhormonaltherapy,anti-inflammatorydrugsandantifibrinolytics.
Key-words Abnormal uterine bleedingdysfunctional uterine bleedingheavy menstrual bleedingmenorrhagiaPALM-COEINSee moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Original Article03-01-2018
Late-Stage Diagnosis of Breast Cancer in Brazil: Analysis of Data from Hospital-Based Cancer Registries (2000-2012)
Revista Brasileira de Ginecologia e Obstetrícia. 2018;40(3):127-136
Views152This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleLate-Stage Diagnosis of Breast Cancer in Brazil: Analysis of Data from Hospital-Based Cancer Registries (2000-2012)
Revista Brasileira de Ginecologia e Obstetrícia. 2018;40(3):127-136
Views152Abstract
Objective
To analyze the time trend and the factors regarding the diagnosis of latestage breast cancer in Brazil from 2000 to 2012.
Methods
We conducted a retrospective cohort study using data from hospital-based cancer registries. Joinpoint regression was used to analyze the time trends of stage at diagnosis. The risk of late-stage presentation was estimated using multinomial logistic regression.
Results
A total of 170,757 cases were analyzed. The median time from diagnosis to treatment was of 43 days (range: 0-182 days). The percentage of cases with late-stage diagnosis decreased from2000 to 2002, with an annual percent change (APC) of -6.6%(95%confidence interval [95%CI]: -7.6–5.5%); it increased from 2002 until 2009, with an APC of 1.1% (95% CI: 0.9-1.3%), and remained stable up to 2012.Women with college education (compared with illiterate women) had less chance of having a late-stage diagnosis (odds ratio [OR]: 0.32; 95%CI: 0.29-0.35). The odds were greater among brown women (OR: 1.30; 95%CI: 1.21-1.41) and black women (OR: 1.63; 95%CI: 1.47-1.82), compared with white women. The odds were also higher for women treated in facilities located and in the Northern region of Brazil (OR: 1.23; 95%CI: 1.04-1.45) and in the Midwest (OR: 1.61;95%CI: 1.34-1.94), compared with those treated in the southern region of the country. Age, histological type, and marital status were some of the other factors that were positively related to staging at the diagnosis.
Conclusion
Access to diagnosis of breast cancer is uneven in Brazil, and women with lower socioeconomic status present a greater probability of having an advanced stage at diagnosis.
Key-words Breast neoplasmsdisease registriesHealth services accessibilityoncologywomen’s health serviceSee moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Search
Search in:
Tag Cloud
Pregnancy (252)Breast neoplasms (104)Pregnancy complications (104)Risk factors (103)Menopause (88)Ultrasonography (83)Cesarean section (78)Prenatal care (71)Endometriosis (70)Obesity (61)Infertility (57)Quality of life (55)prenatal diagnosis (51)Women's health (48)Postpartum period (46)Maternal mortality (45)Pregnant women (45)Breast (44)Prevalence (43)Uterine cervical neoplasms (43)